New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 9, 2012
08:27 EDTUTHRUnited Therapeutics inhaler devices may be recalled, says RBC Capital
After public reports submitted to the FDA indicated that 13 of United Therapeutics' Tyvaso inhalers have emitted smoke, sparkled, sizzled, or caught fire, RBC Capital thinks that the FDA could issue a warning letter about the matter or recall the product. The firm maintains a $45 target and Sector Perform rating on the stock.
News For UTHR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 4, 2015
12:32 EDTUTHRUnited Therapeutics downgraded to Hold from Buy at Standpoint Research
Subscribe for More Information
March 2, 2015
07:20 EDTUTHRCowen to hold a conference
Subscribe for More Information
February 24, 2015
06:19 EDTUTHRUnited Therapeutics reports Q4 Remodulin sales $136.59M
Subscribe for More Information
06:19 EDTUTHRUnited Therapeutics reports Q4 non-GAAP EPS $3.21, consensus $2.03
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use